Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Postoperative Depressive Symptoms in Brain Tumor Resection
NCT03086148Phase 3Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jul 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in major depressive disorder (MDD), sponsored by Beijing Tiantan Hospital. Started Jul 2017; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03086148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03086148.